Skip to Main Content

Paper Details

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Thromb Haemost
182
2020
COVID-19, COVID-19 Thrombosis, Coronavirus disease 2019, SARS, Thromboinflammation, coronavirus 2, patients, severe acute respiratory syndrome, thrombosis, thrombotic disease, viral illness
Author NameAffiliation
Aakriti GuptaNew York-Presbyterian Hospital/Columbia University Irving Medical Center
Aakriti GuptaCenter for Outcomes Research and Evaluation (CORE), Yale School of Medicine
Aakriti GuptaClinical Trials Center, Cardiovascular Research Foundation
Harlan M KrumholzCenter for Outcomes Research and Evaluation (CORE), Yale School of Medicine
Harlan M KrumholzYale School of Public Health
Harlan M KrumholzYale School of Medicine
Harlan M KrumholzCenter for Outcomes Research and Evaluation (CORE), Yale School of Medicine
Harlan M KrumholzYale School of Public Health
Harlan M KrumholzYale School of Medicine
  • 1 - 9

Datasets

Release 1.2